The Indian government has amended drug rules to make oral medications with high alcohol content available only by prescription [1].
This regulatory shift aims to prevent the misuse and diversion of medicinal products used for intoxication. By restricting access, the Ministry of Health and Family Welfare seeks to ensure safer dispensing practices across the country [2].
The changes come via the Drugs 10th Amendment Rules 2026, which modify the original Drugs Rules, 1945 [1]. Under the new mandate, oral formulations that contain more than 12% ethyl alcohol by volume [1] and are sold in containers larger than 30 ml [1] are now classified under Schedule H1.
Schedule H1 is a specific category of drugs that requires a valid prescription from a registered medical practitioner for sale. Pharmacists must also maintain separate records of these sales to track the distribution of the medications [3].
Common medications affected by this change include certain types of cough syrups. Previously, many of these formulations were available over-the-counter, which the government identified as a vulnerability for potential abuse [3].
The rules have been published in the Official Gazette. The government said that the new regulations will take effect six months after the notification date [4].
This transition period allows pharmacies and manufacturers to adjust their labeling, and inventory management to comply with the stricter prescription requirements [4].
“Oral formulations that contain more than 12% ethyl alcohol by volume and are sold in containers larger than 30 ml are now classified under Schedule H1.”
The reclassification of high-alcohol medicines into Schedule H1 signals a move toward tighter pharmaceutical oversight in India. By targeting specific volume and concentration thresholds, the government is attempting to balance medical accessibility with public health safety, specifically targeting the trend of using medicinal syrups as a substitute for recreational alcohol.
